scholarly journals Cost Effectiveness of Gemtuzumab Ozogamicin in the First-Line Treatment of Acute Myeloid Leukaemia in the UK

2021 ◽  
Author(s):  
T. Alexander Russell-Smith ◽  
James Brockbank ◽  
Carla Mamolo ◽  
Christopher Knight
Keyword(s):  
Cost Effectiveness ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Gemtuzumab Ozogamicin ◽  
Line Treatment ◽  
First Line ◽  
The Uk ◽  
First Line Treatment ◽  
Acute Myeloid

Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy

2019 ◽  
Vol 37 (4) ◽  
pp. 447-455 ◽  
Author(s):  
Monica Bocchia ◽  
Anna Candoni ◽  
Erika Borlenghi ◽  
Marzia Defina ◽  
Carla Filì ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Real World ◽  
Intensive Chemotherapy ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment ◽  
Acute Myeloid

scholarly journals Gemtuzumab ozogamicin as first-line treatment in patients aged 70 years or older with acute myeloid leukemia

Cancer ◽  
2010 ◽  
Vol 116 (12) ◽  
pp. 3001-3005 ◽  
Author(s):  
Wassim McHayleh ◽  
Kenneth Foon ◽  
Robert Redner ◽  
Rajesh Sehgal ◽  
Anastasios Raptis ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
Myeloid Leukemia ◽  
Gemtuzumab Ozogamicin ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document